Incyte Corporation - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
INCY Nasdaq 8731 http://www.incyte.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Incyte Corporation

Incyte to Present at Upcoming Investor Conference - Apr 26th, 2018 6:00 am
Incyte Highlights Abstracts Accepted for Presentation at the 2018 ASCO Annual Meeting - Apr 25th, 2018 3:38 pm
Lessons to Learn From April's Biotech Blowups - Apr 25th, 2018 8:33 am
Today's Research Reports on Trending Tickers: Allergan and Incyte Corporation - Apr 25th, 2018 6:30 am
Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug - Apr 24th, 2018 9:59 am
Eli Lilly, Incyte shares drop after mixed FDA drug recommendation - Apr 24th, 2018 5:30 am
Eli Lilly's earnings beat expectations, and its improved outlook overcomes regulatory setback - Apr 24th, 2018 5:03 am
FDA Advisory Committee Recommends the Approval of Baricitinib 2mg, but not 4mg, for the Treatment of Moderately-to-Severely Active Rheumatoid Arthritis - Apr 23rd, 2018 6:10 pm
FDA panel against higher dose of Lilly-Incyte arthritis drug - Apr 23rd, 2018 4:44 pm
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY) - Apr 20th, 2018 8:54 am
3 Biotech Stocks With Major Catalysts Incoming - Apr 20th, 2018 6:03 am
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY - Apr 19th, 2018 3:27 pm
Eli Lilly's Blockbuster Resurrection Story Has Holes - Apr 19th, 2018 12:09 pm
Gilead shares drop on FDA concerns with similar Eli Lilly, Incyte drug - Apr 19th, 2018 12:01 pm
Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug - Apr 19th, 2018 7:10 am
FDA staff cites safety issues for Lilly, Incyte's rheumatoid arthritis drug - Apr 19th, 2018 6:15 am
What Incyte's Phase 3 Fail Means for Immuno-Oncology - Apr 16th, 2018 3:01 pm
NewLink Shares Bite The Dust After Merck-Incyte Melanoma Failure - Apr 16th, 2018 2:21 pm
What's Next for Incyte? - Apr 16th, 2018 2:16 pm
NewLink shares fall on late-stage trial changes - Apr 16th, 2018 6:48 am